Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China

Background: Studies have reported that patients with human immunodeficiency virus (HIV) have a high incidence of osteonecrosis of the femoral head (ONFH). Total hip arthroplasty (THA) is an effective management of ONFH. However, little data exist regarding the use of THA for the HIV patients with ON...

Full description

Bibliographic Details
Main Authors: Chang-Song Zhao, Xin Li, Qiang Zhang, Sheng Sun, Ru-Gang Zhao, Juan Cai
Format: Article
Language:English
Published: Wolters Kluwer 2015-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=15;spage=2059;epage=2064;aulast=Zhao
_version_ 1818176427324866560
author Chang-Song Zhao
Xin Li
Qiang Zhang
Sheng Sun
Ru-Gang Zhao
Juan Cai
author_facet Chang-Song Zhao
Xin Li
Qiang Zhang
Sheng Sun
Ru-Gang Zhao
Juan Cai
author_sort Chang-Song Zhao
collection DOAJ
description Background: Studies have reported that patients with human immunodeficiency virus (HIV) have a high incidence of osteonecrosis of the femoral head (ONFH). Total hip arthroplasty (THA) is an effective management of ONFH. However, little data exist regarding the use of THA for the HIV patients with ONFH in China. This study reviewed the outcomes of HIV-positive patients who underwent THA for ONFH, compared with HIV-negative individuals. Methods: The patients who underwent THA for ONFH from September 2012 to September 2014 in Beijing Ditan Hospital, Capital Medical University were retrospectively studied. Twenty-eight HIV-positive patients and 35 HIV-negative patients underwent 48 THAs and 45 THAs with cementless components, respectively. Medical records and follow-up data were reviewed. Harris Hip Score (HHS) was applied to evaluate the pain and function of the hips before and after THA. Complications such as wound healing, surgical site infection, deep venous thrombosis, pulmonary embolism, sepsis, mortality, and complications from the prosthesis were reviewed. The operation time, blood loss, and hospital stay were compared between the two groups. Results: The mean follow-up period was 19.5 ± 5.8 months (ranging from 6 to 30 months). The mean age of the HIV-positive patients with osteonecrosis at the time of surgery was 35 years old, which was significantly lower than that of the HIV-negative group (42 years old) (P < 0.05). The HIV-positive patients underwent surgery a mean of 2.5 years after their original symptoms, which was significantly shorter than the HIV-negatives′ (mean 4 years) (P < 0.05). Among HIV-positive patients, the prevalence of being male and rate of bilateral procedures were significantly higher than those in the HIV-negative group (P < 0.05). The operation time in HIV-positive patients was significantly longer than that in HIV-negative patients (P < 0.05). There were no significant differences in blood loss or hospital stay between the two groups (P > 0.05). The HHSs of two groups significantly improved after THAs (P < 0.05), without significant difference between two groups. No wound complication, sepsis, mortality, prosthesis complication, and occupational exposure occurred, except for two cases of heterotopic ossification and one case of humeral head necrosis. Conclusions: ONFH is more likely to occur bilaterally in younger HIV-positive males. The development of osteonecrosis seems faster in HIV-positive patients than in HIV-negative patients. This should be cautionary for asymptomatic HIV-positive patients with low viral RNA level and in the primary HIV stage. Despite longer operation times in the HIV-positive patients than in the HIV-negative patients, THA is still a safe and efficient approach to treat ONFH in HIV-positive patients. The incidence of complications is much lower than previously reported. However, the long-term follow-up is needed.
first_indexed 2024-12-11T20:16:01Z
format Article
id doaj.art-60592d1bc31241fbae24ed551531a4d1
institution Directory Open Access Journal
issn 0366-6999
language English
last_indexed 2024-12-11T20:16:01Z
publishDate 2015-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-60592d1bc31241fbae24ed551531a4d12022-12-22T00:52:10ZengWolters KluwerChinese Medical Journal0366-69992015-01-01128152059206410.4103/0366-6999.161364Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in ChinaChang-Song ZhaoXin LiQiang ZhangSheng SunRu-Gang ZhaoJuan CaiBackground: Studies have reported that patients with human immunodeficiency virus (HIV) have a high incidence of osteonecrosis of the femoral head (ONFH). Total hip arthroplasty (THA) is an effective management of ONFH. However, little data exist regarding the use of THA for the HIV patients with ONFH in China. This study reviewed the outcomes of HIV-positive patients who underwent THA for ONFH, compared with HIV-negative individuals. Methods: The patients who underwent THA for ONFH from September 2012 to September 2014 in Beijing Ditan Hospital, Capital Medical University were retrospectively studied. Twenty-eight HIV-positive patients and 35 HIV-negative patients underwent 48 THAs and 45 THAs with cementless components, respectively. Medical records and follow-up data were reviewed. Harris Hip Score (HHS) was applied to evaluate the pain and function of the hips before and after THA. Complications such as wound healing, surgical site infection, deep venous thrombosis, pulmonary embolism, sepsis, mortality, and complications from the prosthesis were reviewed. The operation time, blood loss, and hospital stay were compared between the two groups. Results: The mean follow-up period was 19.5 ± 5.8 months (ranging from 6 to 30 months). The mean age of the HIV-positive patients with osteonecrosis at the time of surgery was 35 years old, which was significantly lower than that of the HIV-negative group (42 years old) (P < 0.05). The HIV-positive patients underwent surgery a mean of 2.5 years after their original symptoms, which was significantly shorter than the HIV-negatives′ (mean 4 years) (P < 0.05). Among HIV-positive patients, the prevalence of being male and rate of bilateral procedures were significantly higher than those in the HIV-negative group (P < 0.05). The operation time in HIV-positive patients was significantly longer than that in HIV-negative patients (P < 0.05). There were no significant differences in blood loss or hospital stay between the two groups (P > 0.05). The HHSs of two groups significantly improved after THAs (P < 0.05), without significant difference between two groups. No wound complication, sepsis, mortality, prosthesis complication, and occupational exposure occurred, except for two cases of heterotopic ossification and one case of humeral head necrosis. Conclusions: ONFH is more likely to occur bilaterally in younger HIV-positive males. The development of osteonecrosis seems faster in HIV-positive patients than in HIV-negative patients. This should be cautionary for asymptomatic HIV-positive patients with low viral RNA level and in the primary HIV stage. Despite longer operation times in the HIV-positive patients than in the HIV-negative patients, THA is still a safe and efficient approach to treat ONFH in HIV-positive patients. The incidence of complications is much lower than previously reported. However, the long-term follow-up is needed.http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=15;spage=2059;epage=2064;aulast=ZhaoArthroplasty; Harris Hip Score; Hip; Human Immunodeficiency Virus Infections; Osteonecrosis of the Femoral Head; Outcomes
spellingShingle Chang-Song Zhao
Xin Li
Qiang Zhang
Sheng Sun
Ru-Gang Zhao
Juan Cai
Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China
Chinese Medical Journal
Arthroplasty; Harris Hip Score; Hip; Human Immunodeficiency Virus Infections; Osteonecrosis of the Femoral Head; Outcomes
title Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China
title_full Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China
title_fullStr Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China
title_full_unstemmed Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China
title_short Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China
title_sort early outcomes of primary total hip arthroplasty for osteonecrosis of the femoral head in patients with human immunodeficiency virus in china
topic Arthroplasty; Harris Hip Score; Hip; Human Immunodeficiency Virus Infections; Osteonecrosis of the Femoral Head; Outcomes
url http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=15;spage=2059;epage=2064;aulast=Zhao
work_keys_str_mv AT changsongzhao earlyoutcomesofprimarytotalhiparthroplastyforosteonecrosisofthefemoralheadinpatientswithhumanimmunodeficiencyvirusinchina
AT xinli earlyoutcomesofprimarytotalhiparthroplastyforosteonecrosisofthefemoralheadinpatientswithhumanimmunodeficiencyvirusinchina
AT qiangzhang earlyoutcomesofprimarytotalhiparthroplastyforosteonecrosisofthefemoralheadinpatientswithhumanimmunodeficiencyvirusinchina
AT shengsun earlyoutcomesofprimarytotalhiparthroplastyforosteonecrosisofthefemoralheadinpatientswithhumanimmunodeficiencyvirusinchina
AT rugangzhao earlyoutcomesofprimarytotalhiparthroplastyforosteonecrosisofthefemoralheadinpatientswithhumanimmunodeficiencyvirusinchina
AT juancai earlyoutcomesofprimarytotalhiparthroplastyforosteonecrosisofthefemoralheadinpatientswithhumanimmunodeficiencyvirusinchina